マルチオミクスの統合による腫瘍型における腫瘍性決定因子の包括的な分析
Saba Ubaid1, Rashmi Kushwaha1, Mohammad Kashif2
1King George's Medical University, Lucknow, India.
Cancer genetics
|September 6, 2025
まとめ
このレビューは,がんの主要な誘発遺伝子の詳細と,がん発症におけるその役割について説明します. パーソナライズされたがん治療のための新しい治療標的を特定するマルチオミックスのデータアイドを統合する.
科学分野:
- 腫瘍学
- 遺伝学
- 分子生物学
背景:
- 癌は遺伝的・表遺伝的変異によって引き起こされる 複雑な病気です
- 主要な癌誘発遺伝子は,腫瘍遺伝子 (例えば,KRAS,PIK3CA) と腫瘍抑制剤 (例えば,TP53,PTEN) を含む.
研究 の 目的:
- 癌を誘発する遺伝子とその分子メカニズムを 総合的に説明する.
- 癌経路と体内の変異の関連性を調べる
- がん研究における新たな概念と治療戦略について議論する.
主な方法:
- 大規模ながんゲノム研究と 全ゲノム配列解析の活用
- マルチオミクスデータを統合する (ゲノミクス,トランスクリプトミクス,プロテオミクス,エピジェノミクス).
- 駆動遺伝子検出 (例えばIntOGen) のためのバイオインフォマティクスプラットフォームを使用する.
主要な成果:
- 癌に関与する重要な腫瘍遺伝子と腫瘍抑制遺伝子を特定した.
- 特徴的な癌経路 (細胞サイクル,アポトーシス,代謝,免疫回避) と関連した体内変異.
- マルチオミクスの統合による新たな原動力変異と腫瘍特有の脆弱性を強調した.
結論:
- マルチオミクスのデータ統合は 癌の生物学を理解するために不可欠です
- 合成的致死性や表遺伝子異常といった 新しい概念が 治療の新たな道を開きます
- バイオマーカーに 基づくパーソナライズされた治療戦略は 患者の治療結果を改善します
さらに関連する動画
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.1K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.8K
関連する概念動画
02:02Genomics
37.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
37.4K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
01:33Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K